NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/23/2026
Back to search
Official data from USPTO
NUACRES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
NUACRES
ST13
US500000079358612Class
1, 5, 42, 44
Filing
79358612
Registration
7781043
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/23/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
11/07/2022
Registration date
05/06/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2025
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
REINHART, MEGHAN M
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Nucleic Acids to the Rescue GmbH
Gentechnologiestiftung -
B. W. (pessoa física)
Representatives
Nicholas D. Wells Legends Law Group, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical or biological substances in the nature of Oligo- and poly-nucleotide arrays for scientific and medical research and reagents for scientific purposes; Chemical or biological substancesmolecular constructs made of DNA or RNA to serve as reagents for research in the field of diagnostics; Chemical or biological molecular constructs made of DNA or RNA for scientific or medical research use; Chemicals and chemical preparations for use in agriculturehorticulture and forestry except fungicidesherbicidesinsecticides and parasiticides
Class 5
Medical and veterinary preparations for the treatment of neoplastic pathologies and infectious diseases; pharmaceuticalsvaccines; biomedical pharmaceutical products for the treatment of neoplastic pathologies and infectious diseases; clinical diagnostic reagents for medical use; therapeutical agent substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies (aptamers); Prophylactical agent substances in the nature of infection prophylactic agents and cancer prophylactic agents; pharmaceutical productsparticularly for the field of oncology and infectiology all in the nature of pharmaceutical products for the prevention and treatment of cancer and infectious diseases; biomedical products based on cytological research substances all in the nature of oligo- and poly-nucleotides and nucleic acid antibodies (aptamers); pharmaceuticalsparticularly for the use in algorithm supported medical treatment all in the nature of pharmaceuticals for treating of infectious diseases and cancer; chemical or biological substances in the nature of oligo- and poly-nucleotides and nucleotids and nucleic acid antibodies (aptamers) and reagents as part of medical and veterinary preparations; chemical or biological substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies all for the treatment of cancer and infectious diseases and reagents for medical and veterinary use; agonists for medical and veterinary use; TLR agonists for medical and veterinary use; agonists as part of medical and veterinary preparations; TLR agonists as part of medical and veterinary preparations
Class 42
Technical services relating to pharmaceutical and medical preparationspharmaceuticals and drugstechnical research in the field of using computers to diagnose disease and health conditions; provision of information relating to medical and veterinary research and developmentparticularly in the field of oncology and infectiology; providing an on-line searchable database in the fields of medical and veterinary research and developmentparticularly in the field of oncology and infectiology; research and development for the pharmaceutical industryparticularly in the field of oncology and infectiology; biomedical research services; research and development services in the field of oncology; research and development services in the field of infectiology; research and development of biomoleculescells and cellular products for medical use; research and development of biomedical productsparticularly therapeutical and prophylactic substances for medical use in the field of oncology and infectiology; research and development in the field of clinical treatment algorithms; medical laboratory services; computer diagnostic servicesparticularly based on clinical treatment algorithms; computer diagnostic servicesparticularly in the field of oncology; computer diagnostic servicesparticularly in the field of infectiology; development of diagnostic apparatus for computer aided medical treatment
Class 44
Medical treatmentsparticularly in the field of oncology and infectiology; medical analysis services related to the treatment of patientsparticularly in the field of oncology and infectiology; medical services in connection with the treatment of cancer; medical testing in connection with the diagnosis and treatment of diseasesparticularly in the field of oncology and infectiology; medical testing for diagnostic or treatment purposesparticularly in the field of oncology and infectiology; medical treatments based on clinical treatment algorithmsparticularly in the field of oncology and infectiology; performance of medical tests related to the diagnosis and treatment of cancer; medical examinations for the diagnosis or treatment of cancer; medical treatments of cancer based on clinical treatment algorithms; medical equipment rentalparticularly for computer aided treatments; medical services; pharmaceutical servicesmonitoring of drug therapy used for cancer and infectious diseases for medical treatment and diagnosis purposes; computer-assisted medical assessment and diagnostical services
Publications
History of USPTO decisions and trademark events.
36 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/11/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/26/2025
FIMP
FINAL DISPOSITION PROCESSED
11/26/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/06/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/06/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
05/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/19/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/19/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/19/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/19/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/19/2025
PUBO
PUBLISHED FOR OPPOSITION
03/18/2025
NPUB
NOTICE OF PUBLICATION
03/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/25/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/25/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/30/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/21/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/14/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/07/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/07/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/29/2024
PBSR
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
04/19/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/17/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2024
RFNT
REFUSAL PROCESSED BY IB
10/17/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/25/2023
RFRR
REFUSAL PROCESSED BY MPU
09/25/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/07/2023
CNRT
NON-FINAL ACTION WRITTEN
09/06/2023
DOCK
ASSIGNED TO EXAMINER
08/22/2023
MAFR
APPLICATION FILING RECEIPT MAILED
12/31/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/27/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/23/2022
Continuous trademark protection
Get notified about every new filing that threatens NUACRES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.